Generex is making a pretty big bet in diagnostic testing with a $10 Million financing proposal for the acquisition of infectious disease and cancer diagnostics company awaiting EUA approval from FDA for COVID-19 rapid diagnostic assay system.
Fyi- Trump’s announcement involves blood plasma research done at the Mayo Clinic.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links